瑞康医药：第五届董事会第二十次会议决议公告

Group 1 - The core point of the article is that Ruikang Pharmaceutical announced the approval of a proposal to change its accounting firm during the 20th meeting of its fifth board of directors held on December 23 [2] Group 2 - The announcement was made public on December 24, indicating the company's ongoing governance and compliance activities [2] - The decision reflects the company's strategic moves in financial management and oversight [2]